Client Result

Cell Therapy Tools Provider Revenue Forecast and Market Positioning

Project Overview

A cell therapy tools and therapeutics developer approached DeciBio to help inform its financial projections, valuation, and messaging to aid its IPO

DeciBio Approach

Primary Research

  • Conducted 31 interviews with cell therapy stakeholders worldwide, across functions from manufacturing to commercial, preclinical, and clinical

Secondary Research

  • Mined data from a proprietary database of >700 cell therapy clinical development programs
  • Segmented the cell therapy clinical pipeline based on vector delivery method, phase of development, cell source, cell type, and indication

Quantitative Analysis

  • Developed a bottom-up 5-year forecast of the number of addressable cell-therapy pharma partners, number of commercial programs, and number of treated patients to forecast the revenue opportunity under various potential business models
At a glance
Cell Therapy Programs Captured

The client leveraged DeciBio's output on its IPO roadshow, ultimately leading to a successful, oversubscribed IPO.


13 weeks

Geographic Scope

U.S., Europe, APAC


Pharma & Biotech


Revenue Projection

Addressable Market Sizing

Novel Technology Commercialization

Related Client Results

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.